Co-inhibition of epidermal growth factor receptor and insulin-like growth factor receptor 1 enhances radiosensitivity in human breast cancer cells

[1]  Ping Li,et al.  Co-inhibition of epidermal growth factor receptor and insulin-like growth factor receptor 1 enhances radiosensitivity in human breast cancer cells , 2013, BMC Cancer.

[2]  R. Stahel,et al.  Starvation-induced activation of ATM/Chk2/p53 signaling sensitizes cancer cells to cisplatin , 2012, BMC Cancer.

[3]  J. Olson,et al.  K-Ras mutation-mediated IGF-1-induced feedback ERK activation contributes to the rapalog resistance in pancreatic ductal adenocarcinomas. , 2012, Cancer letters.

[4]  S. Leung,et al.  Insulin-like growth factor receptor (IGF-1R) in breast cancer subtypes , 2012, Breast Cancer Research and Treatment.

[5]  K. Liang,et al.  Constitutively active Harvey Ras confers resistance to epidermal growth factor receptor-targeted therapy with cetuximab and gefitinib. , 2011, Cancer letters.

[6]  R. Deng,et al.  PKB/Akt promotes DSB repair in cancer cells through upregulating Mre11 expression following ionizing radiation , 2011, Oncogene.

[7]  Kuo Ann Lee,et al.  Hormone receptors and HER-2 status as surrogates for breast cancer molecular subtypes prognosticate for disease control in node negative Asian patients treated with breast conservation therapy. , 2011, Annals of the Academy of Medicine, Singapore.

[8]  D. Powe,et al.  Luminal and basal-like breast cancer cells show increased migration induced by hypoxia, mediated by an autocrine mechanism , 2011, BMC Cancer.

[9]  Qifeng Yang,et al.  Prognostic significance of IGF-1R expression in patients treated with breast-conserving surgery and radiation therapy. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[10]  C. Livasy,et al.  Lapatinib in combination with radiation diminishes tumor regrowth in HER2+ and basal-like/EGFR+ breast tumor xenografts. , 2010, International journal of radiation oncology, biology, physics.

[11]  T. Nielsen,et al.  Breast cancer subtypes and the risk of local and regional relapse. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  F. Liu,et al.  EGFR inhibitor C225 increases the radiosensitivity of human lung squamous cancer cells , 2010, Cancer Cell International.

[13]  J. M. Shields,et al.  Mechanism of lapatinib-mediated radiosensitization of breast cancer cells is primarily by inhibition of the Raf>MEK>ERK mitogen-activated protein kinase cascade and radiosensitization of lapatinib-resistant cells restored by direct inhibition of MEK. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[14]  R C Roovers,et al.  Crosstalk between epidermal growth factor receptor- and insulin-like growth factor-1 receptor signaling: implications for cancer therapy. , 2009, Current cancer drug targets.

[15]  S. Thomson,et al.  Feedback mechanisms promote cooperativity for small molecule inhibitors of epidermal and insulin-like growth factor receptors. , 2008, Cancer research.

[16]  P. Pandolfi,et al.  Inhibition of mTORC1 leads to MAPK pathway activation through a PI3K-dependent feedback loop in human cancer. , 2008, The Journal of clinical investigation.

[17]  K. W. Kim,et al.  Targeting the Akt/mammalian target of rapamycin pathway for radiosensitization of breast cancer , 2006, Molecular Cancer Therapeutics.

[18]  C. Perou,et al.  Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma , 2006, Modern Pathology.

[19]  M. Pollak,et al.  Inhibition of insulin-like growth factor-1 receptor signaling enhances growth-inhibitory and proapoptotic effects of gefitinib (Iressa) in human breast cancer cells , 2005, Breast Cancer Research.

[20]  L Cawkwell,et al.  Radioresistance in carcinoma of the breast. , 2004, Breast.

[21]  C. Shimizu,et al.  Expression of insulin-like growth factor 1 receptor in primary breast cancer: immunohistochemical analysis. , 2004, Human pathology.

[22]  R. Nicholson,et al.  Nonendocrine Pathways and Endocrine Resistance , 2004, Clinical Cancer Research.

[23]  J. Slingerland,et al.  Multiple Roles of the PI3K/PKB (Akt) Pathway in Cell Cycle Progression , 2003, Cell cycle.

[24]  R. Nicholson,et al.  Expanding the therapeutic repertoire of epidermal growth factor receptor blockade: radiosensitization , 2003, Breast Cancer Research.

[25]  Leila Mohammadi,et al.  BMC Cancer , 2001 .

[26]  R. Schmidt-Ullrich,et al.  Radiation-induced release of transforming growth factor alpha activates the epidermal growth factor receptor and mitogen-activated protein kinase pathway in carcinoma cells, leading to increased proliferation and protection from radiation-induced cell death. , 1999, Molecular biology of the cell.